Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma

Autor: Erkki Elonen, Marie Nordström, Jaan Väärt, Mats Jerkeman, Niels Smedegaard Andersen, Mikael Eriksson, Grete F. Lauritzsen, Beatrice Malmer, Anna Laurell, Roald Ekanger, Lone Bredo Pedersen, Lars Møller Pedersen, Anne Marie Boesen, Christian H. Geisler, Herman Nilsson-Ehle, Susanne Fredén, Arne Kolstad

Publikováno v: Andersen, N S, Pedersen, L B, Laurell, A, Elonen, E, Kolstad, A, Boesen, A M, Pedersen, L M, Lauritzsen, G F, Ekanger, R, Nilsson-Ehle, H, Nordström, M, Fredén, S, Jerkeman, M, Eriksson, M, Väärt, J, Malmer, B & Geisler, C H 2009, ' Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma ', Journal of Clinical Oncology, vol. 27, no. 26, pp. 4365-70 . https://doi.org/10.1200/JCO.2008.21.3116

Purpose Minimal residual disease (MRD) is predictive of clinical progression in mantle-cell lymphoma (MCL). According to the Nordic MCL-2 protocol we prospectively analyzed the efficacy of pre-emptive treatment using rituximab to MCL patients in mole

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a47da6558110f4c4db43f5dd1e4f192
https://doi.org/10.1200/jco.2008.21.3116

[Primary treatment of ovarian cancer]

Autor: Anita, Lyngstadaas, Roald, Ekanger, Bjørn, Hagen, Anna, Himmelmann, Ole Erik, Iversen, Torbjørn, Iversen, Randi, Nordal, Ole Frithjof, Norheim, Mathias, Onsrud, Steinar, Tretli, Claes, Tropé

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 125(3)

Patients with epithelial ovarian cancer are often diagnosed with advanced disease; hence they have a generally poor survival rate. The main objective was to assess the clinical effectiveness of the four main treatment options in the primary treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b2dcc07ef32337a8892ad36701a318e
https://pubmed.ncbi.nlm.nih.gov/15702146

Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs

Autor: Robert H. Suva, Jon P. Miller, Stein Ove Døskeland, Dagfinn Øgried, Roald Ekanger

Publikováno v: European Journal of Biochemistry. 181:19-31

cAMP analogs, all 96 of which were modified in the adenine moiety, were examined quantitatively for their ability to inhibit the binding of [3H]cAMP to each of the two classes (A and B) of cAMP-binding sites of type I (rabbit skeletal muscle) and typ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7554f874b7d5ea3fdf1bc25fc20e1c2d
https://doi.org/10.1111/j.1432-1033.1989.tb14689.x

The amounts of rat liver cyclic AMP-dependent protein kinase I and II are differentially regulated by diet

Autor: Olav Karsten Vintermyr, Stein Ove Døskeland, Roald Ekanger

1. The fluctuations in rat hepatocyte volume and protein content in response to dietary perturbations (starvation, protein restriction, refeeding) were accompanied by corresponding fluctuations in the amount of the regulatory (R) and catalytic (C) su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ea39382583a61517df55889b7b2759
https://europepmc.org/articles/PMC1135430/

Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3',5'-phosphate dependent protein kinase I

Autor: Roald Ekanger, Dagfinn Oegreid, Jon P. Miller, Robert H. Suva, Priscilla A. Sturm, Stein O. Doeskeland

Publikováno v: Biochemistry. 22(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3fe92b58b40fd375439242ebf4bbf2
https://pubmed.ncbi.nlm.nih.gov/6301537